BLCO Bausch & Lomb Corp
NYSE · SEC CIK 1860742 · EDGAR
- Bought, last 12 months
- $1.22M 9 purchases by 9 insiders
- Sold, last 12 months
- $1.19M 2 sales by 2 insiders
- Filings on record
- 209 since 2022-05-09, latest 2026-08-14 17:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Munsch Frederick | SVP, CAO, Ctrl | — | $887.7K |
| VON ESCHENBACH ANDREW C. | Dir | $79.9K | $306.7K |
| COLLIS STEVEN H | Dir | $267.1K | — |
| SAUNDERS BRENT L | COB, CEO, Dir | $252.0K | — |
| Bailey A Robert D | EVP, CLO | $250.4K | — |
| Ross Thomas W. Sr. | Dir | $79.6K | — |
| ROBERTSON RUSSEL C | Dir | $78.8K | — |
| Alfonso Eduardo | Dir | $77.0K | — |
| Ling Karen | Dir | $71.0K | — |
| Eldessouky Sam | EVP, CFO | $68.5K | — |
Transactions 219
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-27 | 2022-07-25 | BLCO | ACKERMANN CHRISTINA | Please see remarks | A - Grant | $0.00 | +35.0K | 118.3K | +42% | $0 | |
| 2022-07-05 | 2022-06-30 | BLCO | Bernier Nathalie D. | Dir | A - Grant | $15.24 | +748 | 13.2K | +6% | +$11.4K | |
| 2022-06-30 | 2022-06-28 | BLCO | Hu Gaoxiang | Dir | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 | |
| 2022-06-30 | 2022-06-28 | BLCO | ICAHN BRETT | Dir | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 | |
| I | 2022-06-02 | 2022-06-01 | BLCO | Bausch Health Companies Inc. | 10% | S - Sale | $17.06 | -4.55M | 310.45M | -1% | -$77.63M |
| 2022-05-12 | 2022-05-10 | BLCO | DE SCHUTTER RICHARD U | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| I | 2022-05-12 | 2022-05-10 | BLCO | Bausch Health Companies Inc. | 10% | S - Sale | $17.06 | -35.00M | 315.00M | -10% | -$597.10M |
| 2022-05-12 | 2022-05-10 | BLCO | ROBERTSON RUSSEL C | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | Bernier Nathalie D. | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | VON ESCHENBACH ANDREW C. | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | Ross Thomas W. Sr. | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | Paulson John | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 | |
| D | 2022-05-09 | 2022-05-05 | BLCO | ACKERMANN CHRISTINA | Please see remarks | A - Grant | $0.00 | +83.3K | 83.3K | New | $0 |
| D | 2022-05-09 | 2022-05-05 | BLCO | Munsch Frederick | SVP, CAO, Ctrl | A - Grant | $0.00 | +22.2K | 22.2K | New | $0 |
| D | 2022-05-09 | 2022-05-05 | BLCO | PAPA JOSEPH C | CEO, COB, Dir | A - Grant | $0.00 | +472.2K | 472.2K | New | $0 |
| D | 2022-05-09 | 2022-05-05 | BLCO | Eldessouky Sam | CFO | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
| D | 2022-05-09 | 2022-05-05 | BLCO | Hashad Yehia | EVP, CMO, R, D | A - Grant | $0.00 | +34.7K | 34.7K | New | $0 |
| D | 2022-05-09 | 2022-05-05 | BLCO | Gordon Joseph F | Please see remarks | A - Grant | $0.00 | +69.4K | 69.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations